AI assistant
Sending…
Arcadia Biosciences, Inc. — Director's Dealing 2019
Sep 18, 2019
35424_dirs_2019-09-17_d69e266a-e342-4f1f-b0bf-bb98faafa00f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Arcadia Biosciences, Inc. (RKDA)
CIK: 0001469443
Period of Report: 2019-09-17
Reporting Person: Comcowich Kevin (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-09-17 | Common Stock | P | 5000 | $5.8776 | Acquired | 20000 | Direct |
More from Arcadia Biosciences, Inc.
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
Apr 3
Board/Management Information
2026
Feb 6
Capital/Financing Update
2026
Jan 28
Capital/Financing Update
2026
Jan 14
M&A Activity
2025
Dec 29
Regulatory Filings
2025
Dec 29
Declaration of Voting Results & Voting Rights Announcements
2025
Dec 23
Annual Report
2025
Nov 19